Access cutting-edge chronic hepatitis b treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access chronic hepatitis b specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic hepatitis b treatment provided free
This is a Phase 2 study to evaluate efficacy and safety of 48 weeks of oral once daily monotherapy with ALG-000184 versus tenofovir disproxil fumarate (TDF) for chronic HBV infection.
Sponsor: Aligos Therapeutics
Check if you qualify for this chronic hepatitis b clinical trial in San Francisco, CA
If you're searching for chronic hepatitis b treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic hepatitis b specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.